Guler OC[au] - Search Results

Year	Number of Results
2013	4
2014	6
2015	6
2016	6
2017	6
2018	13
2019	15
2020	18
2021	22
2022	2

1

In Regard to Harmon et al.

Guler OC, Onal C. Guler OC, et al. Int J Radiat Oncol Biol Phys. 2022 Feb 1;112(2):572-573. doi: 10.1016/j.ijrobp.2021.09.037. Int J Radiat Oncol Biol Phys. 2022. PMID: 34998536 No abstract available.

2

In Regard to Deek et al.

Onal C, Guler OC, Oymak E. Onal C, et al. Among authors: guler oc. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1546-1547. doi: 10.1016/j.ijrobp.2021.04.004. Int J Radiat Oncol Biol Phys. 2021. PMID: 34273330 No abstract available.

3

In Regard to Hall et al.

Onal C, Oymak E, Guler OC. Onal C, et al. Among authors: guler oc. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):619-620. doi: 10.1016/j.ijrobp.2021.01.040. Int J Radiat Oncol Biol Phys. 2021. PMID: 33989588 No abstract available.

4

Metachronous Prostate Metastasis of Renal Cell Carcinoma: Case Report and Review of the Literature.

Guler OC, Bal N, Onal C. Guler OC, et al. Clin Genitourin Cancer. 2016 Apr;14(2):e211-3. doi: 10.1016/j.clgc.2015.11.015. Epub 2015 Nov 26. Clin Genitourin Cancer. 2016. PMID: 26739102 Review. No abstract available.

5

Radiotherapy After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction.

Yuce Sari S, Guler OC, Gultekin M, Akkus Yildirim B, Onal C, Ozyigit G, Yildiz F. Yuce Sari S, et al. Among authors: guler oc. Clin Breast Cancer. 2019 Oct;19(5):e611-e616. doi: 10.1016/j.clbc.2019.04.002. Epub 2019 Apr 11. Clin Breast Cancer. 2019. PMID: 31255547

6

Graves' ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature.

Guler OC, Onal C, Arslan G. Guler OC, et al. Wien Klin Wochenschr. 2016 Apr;128(7-8):299-303. doi: 10.1007/s00508-015-0870-z. Epub 2015 Oct 14. Wien Klin Wochenschr. 2016. PMID: 26466836 Review.

7

Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients.

Onal C, Torun N, Akyol F, Guler OC, Hurmuz P, Yildirim BA, Cağlar M, Reyhan M, Ozyigit G. Onal C, et al. Among authors: guler oc. Clin Nucl Med. 2019 Sep;44(9):e510-e516. doi: 10.1097/RLU.0000000000002691. Clin Nucl Med. 2019. PMID: 31283600

8

Incidental testicular doses during volumetric-modulated arc radiotherapy in prostate cancer patients.

Onal C, Bozca R, Dolek Y, Guler OC, Arslan G. Onal C, et al. Among authors: guler oc. Radiol Med. 2020 Aug;125(8):777-783. doi: 10.1007/s11547-020-01158-2. Epub 2020 Mar 3. Radiol Med. 2020. PMID: 32125635

9

The hematologic parameters in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

Onal C, Sedef AM, Kose F, Oymak E, Guler OC, Sumbul AT, Aksoy S, Akkus Yildirim B, Besen AA, Muallaoglu S, Mertsoylu H, Ozyigit G. Onal C, et al. Among authors: guler oc. Future Oncol. 2019 May;15(13):1469-1479. doi: 10.2217/fon-2018-0635. Epub 2019 Apr 12. Future Oncol. 2019. PMID: 30977383

10

Prostate mucinous carcinoma treated with definitive radiotherapy and hormonal therapy: case report and review of the literature.

Guler OC, Onal C, Erbay G, Bal N. Guler OC, et al. Clin Genitourin Cancer. 2014 Apr;12(2):e43-6. doi: 10.1016/j.clgc.2013.11.018. Epub 2013 Nov 12. Clin Genitourin Cancer. 2014. PMID: 24365124 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results